跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Duvadilan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Duvadilan
Approved
STANDARD
Duvadilan
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
16ebb34293603af5
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
16ebb34293603af5
Drug Approval Philippines Name
Duvadilan
Product Name
Duvadilan
Registration Number
DR-7352
Brand Name
Duvadilan
Generic Name
Isoxsuprine Hydrochloride
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Interphil Laboratories, Inc.
Distributor
Zuellig Pharma Corporation
Issuance Date
25 July 2024
Expiry Date
20 August 2029
Pharmacologic Category
Tocolytic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
16ebb34293603af5
Type
Standard
Back to Philippines FDA Approvals